Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk" is generating significant coverage in the Health category, with 8 articles from 8 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Inside Precision Medicine, tum.de, TCTMD.com and News-Medical. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Quick answers
Why is "Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- MACE Risk May Be Reduced with GLP-1 Drug in High-Risk Patients Inside Precision Medicine · 47d ago
- Obesity drug significantly reduces the risk of serious cardiovascular events and infections tum.de · 47d ago
- Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes TCTMD.com · 47d ago
- Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes News-Medical · 47d ago
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics U.S. News & World Report · 47d ago
- Obesity drug significantly reduces the risk of serious cardiovascular events and infections Deutsches Zentrum für Herz-Kreislauf-Forschung · 47d ago
- GLP-1 drugs like Mounjaro may help lower heart attack risk by 33% Medical News Today · 47d ago
- Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk Healthline · 47d ago
Topics
Related trends
China May Reopen Nvidia's AI Market. How Will NVDA Stock React Monday?
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Does GLP-1 use result in significant hair loss?
Recent coverage examines whether the widespread use of GLP-1 medications leads to significant hair loss for patients.
GLP-1 Prescriptions for People With No Medical Need Are Climbing
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
GLP-1 lawsuit: Patient’s attorney describes life-changing effects from taking drug
GLP-1 drug makers confront a wave of lawsuits alleging permanent vision loss, sparking debate over proof and patient warnings.
Xbox Studio 'World's Edge' May Have Cancelled A Game As Part Of Activision Shift
Xbox Studio 'World's Edge' is reportedly cancelling a project amid a broader strategic shift following the Activision acquisition.
Exercise May Match Common Pain Medications, Major Review Finds
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.